Is Quercetin Inflammation Meta-Analysis safe?

Updated May 2026

Quick Answer

Quercetin Inflammation Meta-Analysis has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Although existing therapies, including corticosteroids, antivirals, and immunosuppressants, can delay progression of disease, they are often associated with high costs, side effects, and decreased long-term efficacy [].

Key Takeaways

  • 01Although existing therapies, including corticosteroids, antivirals, and immunosuppressants, can delay progression of disease, they are often associated with high costs, side effects, and decreased long-term efficacy []. [Dogra Shivani (2026)]
  • 02Flavonoids comprise a structurally diverse group of naturally occurring polyphenolic compounds abundantly found in grains, tea, fruits, vegetables, and numerous medicinal plants [,,]. [Dogra Shivani (2026)]
  • 03The purpose of this review is to consolidate current mechanistic evidence of flavonoid-mediated redox regulation in liver disease, with particular emphasis on intracellular signalling pathways and gut–liver interactions, and to assess their potential therapeutic relevance. [Dogra Shivani (2026)]
  • 04It plays a central role in maintaining the metabolism of lipids, proteins, and carbohydrates, thereby supporting overall physiological balance. [Dogra Shivani (2026)]
The current Migaku evidence database contains 2 reusable source documents for Quercetin Inflammation Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts. - Although existing therapies, including corticosteroids, antivirals, and immunosuppressants, can delay progression of disease, they are often associated with high costs, side effects, and decreased long-term efficacy []. [Dogra Shivani (2026); evidence level 3] - Flavonoids comprise a structurally diverse group of naturally occurring polyphenolic compounds abundantly found in grains, tea, fruits, vegetables, and numerous medicinal plants [,,]. [Dogra Shivani (2026); evidence level 3] - The purpose of this review is to consolidate current mechanistic evidence of flavonoid-mediated redox regulation in liver disease, with particular emphasis on intracellular signalling pathways and gut–liver interactions, and to assess their potential therapeutic relevance. [Dogra Shivani (2026); evidence level 3] - It plays a central role in maintaining the metabolism of lipids, proteins, and carbohydrates, thereby supporting overall physiological balance. [Dogra Shivani (2026); evidence level 3] - Background Liver inflammation and fibrosis are directly associated with non-alcoholic fatty liver disease (NAFLD). [Alqahtani SA (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Redox Reprogramming of the Diseased Liver by Dietary Flavonoids: From Molecular Signalling to Gut–Liver Crosstalk
  2. Quercetin Attenuates Non-Alcoholic Fatty Liver Disease in Association with the Inhibition of Hepatic IL-1β/iNOS and IL-1β/CD45 Axes of Inflammation and Fibrosis Accompanied by Reduced Endogenous Metabolites and Apoptosis.